Listing analysis and research matching GSK:
GSK announces Chinese neurology research center
GlaxoSmithKline has announced a new Chinese research and development centre to add to its 32 research sites around the world. The centre is to be based in Shanghai and will be focused on the development of drugs to treat neurodegenerative disorders such as multiple sclerosis, Parkinson's disease and Alzheimer's disease.
Public-private partnerships for drug development: An emerging trend or special cases?
On November 5th 2007 the pharmaceutical company GlaxoSmithKline announced that it had formed a five year alliance with the Texan based non-profit research institution MD Anderson Cancer Center to discover and develop new therapeutic, diagnostic and imaging products for cancer.
